XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   42,526    
Beginning balance at Dec. 31, 2023 $ 655,501 $ 4 $ 869,918 $ (214,421)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense 24,985   24,985  
Stock options exercised (in shares)   326    
Stock options exercised 3,610   3,610  
Release of restricted stock units (in shares)   205    
Net income 26,956     26,956
Ending balance (in shares) at Mar. 31, 2024   43,057    
Ending balance at Mar. 31, 2024 711,052 $ 4 898,513 (187,465)
Beginning balance (in shares) at Dec. 31, 2024   44,936    
Beginning balance at Dec. 31, 2024 824,550 $ 4 950,393 (125,847)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense $ 31,018   31,018  
Stock options exercised (in shares) 276 276    
Stock options exercised $ 3,123   3,123  
Release of restricted stock units (in shares)   204    
Net income 35,135     35,135
Ending balance (in shares) at Mar. 31, 2025   45,416    
Ending balance at Mar. 31, 2025 $ 893,826 $ 4 $ 984,534 $ (90,712)